stonkbuilderCOMMUNITY NeuralinkVideos25DgJNGwC0g
Independent Research Notice: Independent StonkBuilder Community research publication. Not affiliated with, operated by, or endorsed by Neuralink Corp. or PreStocks. Neuralink devices are investigational and have not received FDA marketing authorization. Nothing here is medical, legal, or financial advice. PreStocks tokens are not Neuralink shares, confer no shareholder rights, and are unavailable to U.S. persons and residents of prohibited jurisdictions.

Shape the Future of Assistive Technology with Neuralink: technical breakdown, key moments and clinical context

Published on 16 May 2024 ('Shape the Future of Assistive Technology with Neuralink', 1:31), this official clinical-trial recruitment film invites adults with quadriplegia from spinal cord injury or ALS to apply to the Neuralink Patient Registry and explains how the PRIME Study evaluates wireless computer control.

16 May 2024Published dateOfficial @neuralink Video · 1:31
25DgJNGwC0gYouTube Video IDChannel UCLt4d8cACHzrVvAz9gtaARA · Embeddable (200 OK)
Tier 1Evidence classClinical Trial Recruitment (PRIME)
Clinical trials, keynotes & vision researchPrimary topicPaired with /neuralink/prime-convoy-voice-trials
Key points
  • Primary record: Official @neuralink video (25DgJNGwC0g) published on 16 May 2024 (duration 1:31).
  • What it shows: Official patient-registry recruitment scope and investigational disclaimers for the PRIME Study.
  • Technical pathway: Patient Registry application (neuralink.com/patient-registry) → clinical screening → PRIME trial (NCT06429735).
  • Evidence boundary: 1:31 recruitment and educational overview video (May 2024).

Watch the official video record

Poster illustration for Shape the Future of Assistive Technology with Neuralink
Official @neuralink Video 16 May 2024 · 1:31 Tier 1 · Clinical Trial Recruitment (PRIME)
Shape the Future of Assistive Technology with Neuralink

Click to load the privacy-enhanced youtube-nocookie.com player. No third-party cookies or requests are sent until you press play.

Watch on YouTube ↗
Source: Neuralink (@neuralink) · Channel UCLt4d8cACHzrVvAz9gtaARA · Video 25DgJNGwC0g · Checked 30 Oct 2026 Direct YouTube link ↗

Official upload from @neuralink (16 May 2024, 1:31).

Read verbatim official @neuralink YouTube description & caption provenance

Caption & verification basis: English auto-generated captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).

We are seeking people with quadriplegia to participate in a groundbreaking investigational medical device clinical trial for our brain-computer interface.

Learn more and submit an application:
neuralink.com/patient-registry

—

The ability to interface with digital devices and the Internet is a requirement for functioning in an increasingly digital society. Unfortunately, the input systems that are currently available to many people with quadriplegia often fail to meet their needs, leading to decreased engagement in society and increased dependency on others.

Our implant is designed to establish a wireless, digital link between the brain and computers to potentially provide individuals with paralysis the same reliable control over smart devices as able-bodied individuals have (if not better). 

This study aims to validate the safety and usefulness of our implant and surgical robot - an important step towards shaping the future of assistive technologies that will potentially help millions of people around the world suffering from quadriplegia and other neurological conditions.

—

"Action Time" by Cold Cinema
inaudio.org/track/action-time-epic

Technical pathway and evidence classification

Video notes · 16 May 2024 · Video (1:31) PRIME Study Patient Registry Call for Volunteers
EVIDENCE CLASSIFICATION Tier 1 · Clinical Trial Recruitment (PRIME) Video ID: 25DgJNGwC0g Published: 16 May 2024 (1:31) PRIMARY SUBSYSTEM Clinical trials, keynotes & vision Channel: @neuralink (verified) Embed: Embeddable (youtube-nocookie) INTERPRETATION BOUNDARY Investigational Context Not FDA marketing approval Verify against clinical registries
Technical pathway Signal & hardware chain

Patient Registry application (neuralink.com/patient-registry) → clinical screening → PRIME trial (NCT06429735)

Analytical scope What to keep in mind

1:31 recruitment and educational overview video (May 2024).

Timestamped breakdown and key moments

Sequential moments in Shape the Future of Assistive Technology with Neuralink (1:31)
TimestampSegment / eventWhat happens in the segment
00:00Limitations of current assistive inputsExplains why existing switches and eye-trackers often leave people with quadriplegia dependent on others.
00:45Wireless N1 cursor control & Patient RegistryShows first-participant laptop use and directs prospective volunteers to neuralink.com.

What this video demonstrates—and what it does not establish

What this video demonstrates

  • Official patient-registry recruitment scope and investigational disclaimers for the PRIME Study.

Scope limits & what it does not establish

  • Recruitment overview; explicitly notes that the study evaluates safety and initial usefulness with no guaranteed benefit.

How this fits into Neuralink's broader clinical and hardware roadmap

This video sits inside the Clinical trials, keynotes & vision research research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at Clinical trials, keynotes & vision research for cohort context.

Sources checked 30 Oct 2026

Sources and official records

  1. [1] Neuralink YouTube (2024-05-16): Shape the Future of Assistive Technology with Neuralink · Verified 30 Oct 2026
  2. [2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) · Verified 30 Oct 2026
  3. [3] Neuralink: Official website and investigational device notice · Verified 30 Oct 2026
  4. [4] Neuralink: Clinical Trials and Patient Registry · Verified 30 Oct 2026
  5. [5] ClinicalTrials.gov: The PRIME Study (NCT06429735) · Verified 30 Oct 2026
  6. [6] Neuralink: Two Years of Telepathy (28 Jan 2026) · Verified 30 Oct 2026